The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat

Stress

Volumn 9, Issue 1, 2006, Pages 21-28

  Sajdyk, Tammy J ^a,b   Fitz, Stephanie D ^a   Shekhar, Anantha ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Anxiety; Conditioned place avoidance; Emotional homeostasis; Restraint stress; Social interaction; Urocortin I

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; NEUROPEPTIDE Y; UROCORTIN;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; EMOTIONAL STRESS; IMMOBILIZATION STRESS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL INTERACTION; STRESS; TASK PERFORMANCE;

AMYGDALA; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; MALE; NEUROPEPTIDE Y; RATS; RATS, WISTAR; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RESTRAINT, PHYSICAL; SOCIAL BEHAVIOR; STRESS, PSYCHOLOGICAL;

EID: 33744999429     PISSN: 10253890     EISSN: 16078888     Source Type: Journal    
DOI: 10.1080/10253890600557315     Document Type: Article

References (43)

1. Berglund MM, Hipskind PA, Gehlert DR. 2003. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med (Maywood) 228(3):217-244.
2. Bi S, Ladenheim EE, Schwartz GJ, Moran TH. 2001. A role for NPY overexpression in the dorsomedial hypothalamus in hyperphagia and obesity of OLETF rats. Am J Physiol Regul Integr Comp Physiol 281(1):R254-R260.
3. Cador M, Ahmed SH, Koob GF, Le Moal M, Stinus L. 1992. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role. Brain Res 597(2):304-309.
4. Chaki S, Nakazato A, Kennis L, Nakamura M, Mackie C, Sugiura M, Vinken P, Ashton D, Langlois X, Steekler T 2004. Anxiolytic- and antidepressant-like profile of a new CRF1 receptor antagonist, R278995/CRA0450. Eur J Pharmacol 485(1-3):145-158.
5. Costoli T, Sgoifo A, Stilli D, Flugge G, Adriani W, Laviola G, Fuchs E, Pedrazzini T, Musso E. 2005. Behavioural, neural and cardiovascular adaptations in mice lacking the NPY Y1 receptor. Neurosci Biobehav Rev 29(1):113-123.
6. Dautzenberg FM, Hauger RL. 2002. The CRF peptide family and their receptors: Yet more partners discovered. Trends Pharmacol Sci 23(2):71-77.
7. Duhault J, Boulanger M, Chamorro S, Boutin JA, Della Zuana O, Douillet E, Fauchere JL, Feletou M, Germain M, Husson B, Vega AM, Renard P, Tisserand F. 2000. Food intake regulation in rodents: Y5 or Y1 NPY receptors or both? Can J Physiol Pharmacol 78(2):173-185.
8. Gehlert DR. 1998. Multiple receptors for the pancreatic polypeptide (PP-fold) family: Physiological implications. Proc Soc Exp Biol Med 218(1):7-22.
9. Gehlert DR, Shekhar A, Morin SM, Hipskind PA, Zink C, Gackenheimer S, Shaw J, Fitz SD, Sajdyk TJ. 2005. Stress and central urocortin increase anxiety-like behavior in the social interaction test via a CRF1 receptor. Eur J Pharmacol 509(2-3):145-153.
10. Heilig M, McLeod S, Brot M, Heinrichs SC, Menzaghi F, Koob GF, Britton KT 1993. Anxiolytic-like action of neuropeptide Y: Mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology 8(4):357-363.
11. Heilig M, Koob GF, Ekman R, Britton KT 1994. Corticotropin-releasing factor and neuropeptide Y: Role in emotional integration. Trends Neurosci 17(2):80-85.
12. Heinrichs SC, Lapsansky J, Lovenberg TW, De Souza EB, Chalmers DT 1997. Corticotropin-releasing factor CRF1, but not CRF2, receptors mediate anxiogenic-like behavior. Regul Pept 71(1):15-21.
13. Lovenberg TW, Liaw CW, Grigoriadis DE, Clevenger W, Chalmers DT, De Souza EB, Oltersdorf T 1995. Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. Proc Natl Acad Sci USA 92(3):836-840.
14. McGaugh JL. 2002. Memory consolidation and the amygdala: A systems perspective. Trends Neurosci 25(9):456.
15. Merali Z, McIntosch J, Kent P, Michaud D, Anisman H. 1998. Aversive and appetitive events evoke the release of corticotropin-releasing hormone and bombesin-like peptides at the central nucleus of the amygdala. J Neurosci 18:4758-4788.
16. Parker RM, Herzog H. 1999. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11(4):1431-1448.
17. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. 2 ed. New York: Academic Press.
18. Pich ME, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. 1995. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J Neurosci 15(8):5439-5447.
19. Rainnie DG, Bergeron R, Sajdyk TJ, Patil M, Gehlert DR, Shekhar A. 2004. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. J Neurosci 24(14):3471-3479.
20. Reul JM, Holsboer F. 2002. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2(1):23-33.
21. Risbrough VB, Hauger RL, Roberts AL, Vale WW, Geyer MA. 2004. Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior. J Neurosci 24(29):6545-6552.
22. Roozendaal B, Brunson KL, Holloway BL, McGaugh JL, Baram TZ. 2002. Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc Natl Acad Sci USA 99(21):13908-13913.
23. Roskoden T, Hanke J, Yilmazer-Hanke D, Schwegler H. 2005. Reduced number of CRF-containing neurons in the central amygdala correlated with enhanced locomotor activity following early postnatal corticosterone treatment in the Wistar rat. Behav Brain Res 165(2):221-228.
24. Sajdyk TJ, Shekhar A. 1997. Excitatory amino acid receptor antagonists block the cardiovascular and anxiety responses elicited by gamma-aminoburyric acidA receptor blockade in the basolateral amygdala of rats. J Pharmacol Exp Ther 283(2):969-977.
25. Sajdyk TJ, Gehlert DR. 2000. Astressin, a corticotropin releasing factor antagonist, reverses the anxiogenic effects of urocortin when administered into the basolateral amygdala. Brain Res 877(2):226-234.
26. Sajdyk TJ, Schober DA, Gehlert DR, Shekhar A. 1999a. Role of corticotropin-releasing factor and urocortin within the basolateral amygdala of rats in anxiety and panic responses. Behav Brain Res 100(1-2):207-215.
27. Sajdyk TJ, Vandergriff MG, Gehlert DR. 1999b. Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test. Eur J Pharmacol 368:143-147.
28. Sajdyk TJ, Schober DA, Gehlert DR. 2002a. Neuropeptide Y receptor subtypes in the basolateral nucleus of the amygdala modulate anxiogenic responses in rats. Neuropharmacology 43(7):1165-1172.
29. Sajdyk TJ, Schober DA, Smiley DL, Gehlert DR. 2002b. Neuropeptide Y-Y2 receptors mediate anxiety in the amygdala. Pharmacol Biochem Behav 71(3):419-423.
30. Sajdyk TJ, Shekhar A, Gehlert DR. 2004. Interactions between NPY and CRF in the amygdala regulate emotionality. Neuropeptides 38(4):225-234.
31. Sajdyk TJ, Fitz SD, Merrill C, Conroy S, Chambers R, Shekhar A. 2005. Behavioral profile of rats following CRF-mediated stressors. Paper presented at the Annual Meeting of Society For Neuroscience. Washington, DC.
32. Sanchez MM, Young LJ, Plotsky PM, Insel TR. 1999. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J Comp Neurol 408(3):365-377.
33. Sanders SA. 1995. GABAA receptors in the basolateral amygdala of rats regulate "anxiety". Pharmacol Biochem Behav 37:701-706.
34. Sanders SK, Morzorati SL, Shekhar A. 1995. Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala. Brain Res 699(2):250-259.
35. Shekhar A, Katner JS. 1995. Dorsomedial hypothalamic GABA regulates anxiety in the social interaction test. Pharmacol Biochem Behav 50(2):253-258.
36. Shekhar A, Sajdyk TJ, Gehlert DR, Rainnie DG. 2003. The amygdala, panic disorder, and cardiovascular responses. Ann NY Acad Sci 985:308-325.
37. Sheriff S, Dautzenberg FM, Mulchahey JJ, Pisarska M, Hauger RL, Chance WT, Balasubramaniam A, Kasckow JW 2001. Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells. Peptides 22(12):2083-2089.
38. Thorsell A, Caberlotto L, Rimondini R, Heilig M. 2002. Leptin suppression of hypothalamic NPY expression and feeding, but not amygdala NPY expression and experimental anxiety. Pharmacol Biochem Behav 71(3):425-430.
39. Thorsell A, Heilig M. 2002. Diverse functions of neuropeptide Y revealed using genetically modified animals. Neuropeptides 36(2-3):182-193.
40. Thorsell A, Svensson P, Wiklund L, Sommer W, Ekman R, Heilig M. 1998. Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress. Regul Pept 75-76:247-254.
41. Van Pert K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale W, Sawchenko PE. 2000. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428(2):191-212.
42. Valdez GR, Sabino V, Koob GR 2004. Increased anxiety-like behavior and ethanol self-administration in dependent rats: Reversal via corticotropin- releasing factor-2 receptor activation. Alcohol Clin Exp Res 28(6):865-872.
43. Wolak ML, deJoseph MR, Cator AD, Mokashi AS, Brownfield MS, Urban JH. 2003. Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry. J Comp Neurol 464:285-311.